03 September 2010
Keywords: USA, Consumer Reports, Heartburn, Nexium, GERD
Article | 30 October 2009
Last year, US consumers and their insurance companies spent $4.8 billion on Nexium (esomeprazole, a blockbuster drug from AstraZeneca) one of six proton pump inhibitors (PPIs) currently available, making "the purple pill" the second highest-selling drug in 2008, behind Lipitor (atorvastatin, the cholesterol-lowering, all-time biggest selling drug from Pfizer, reports Consumer Reports’ Best Buy Drugs. “It's no wonder: a month's supply of Nexium has a retail price tag of up to $240 a month, compared to just $24 a month for an over-the-counter PPI,” it observes.
"For most consumers, over-the-counter, generic drugs will treat their frequent heartburn and acid reflux just as well as more expensive prescription drugs, and save them money too," said Lisa Gill, editor, prescription drugs, Consumer Reports Health. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.